SGLT2 inhibitors and GLP‐1 receptor agonists modestly lower blood pressure across diverse patient populations, including those without diabetes. These effects appear largely independent of glycaemic control and offer additive value in high‐risk patients with overlapping comorbidities.
Andrej Belančić +7 more
wiley +1 more source
Correction: Association between systemic immune-inflammation index(SII) and all-cause and cardiovascular mortality in heart failure patients: a single-center retrospective analysis. [PDF]
Zhang J +9 more
europepmc +1 more source
Association of neutrophil-lymphocyte ratio with all-cause and cardiovascular mortality in peritoneal dialysis patients: A systematic review and meta-analysis. [PDF]
Damarlapally N +11 more
europepmc +1 more source
Response to letter regarding associations of dietary indices with risk of all-cause and cardiovascular mortality in hypertensive adults. [PDF]
Chen F.
europepmc +1 more source
Prognostic effect of estimated glucose disposal rate on all-cause and cardiovascular mortality among individuals cardiovascular-kidney-metabolic syndrome. [PDF]
Shao J +8 more
europepmc +1 more source
Associations of dietary live microbe intake with all-cause and cardiovascular mortality in middle-aged and older US stroke survivors: a prospective cohort study from NHANES 2003-2018. [PDF]
Chen W +5 more
europepmc +1 more source
Related searches:
Cardiovascular Contribution to Maternal Mortality
Cardiology Clinics, 2021The United States is the only industrialized nation with an increasing maternal mortality. Many factors contribute to this worrisome US trend; among them, social and demographic factors, and congenital and acquired cardiac conditions. Cardiovascular disease is the leading cause of maternal mortality, and adverse outcomes related to cardiovascular ...
Anna, Grodzinsky, Laura, Schmidt
openaire +2 more sources

